Pr. Jean-Marc Cosset
Le Professeur Jean-Marc COSSET a successivement exercé les fonctions de chef de service de Radiothérapie à l’Institut Gustave Roussy, puis de Chef du Département d’Oncologie/Radiothérapie de l’Institut Curie.
Il a rejoint en 2016 le Groupe Amethyst, avec la fonction de Directeur médical pour les centres Français.
Il été longtemps responsable d’enseignement pour la Radiothérapie, la Radiobiologie et la Radioprotection au niveau national et européen, et a été 41 fois président de jurys de Thèse de Sciences.
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Occupational Radiological Protection in Brachytherapy
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
COVID-19-Associated Pneumonia: Radiobiological Insights
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Irradiation à faible dose des affections non cancéreuses : avons-nous jeté le bébé avec l’eau du bain ?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Low dose lung radiotherapy for covid-19-related cytokine storm syndrome: why not?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects.
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Is there any benefit to particles over photon radiotherapy?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Reirradiations: Which decision-making criteria?
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Which alpha/beta ratio for prostate cancer in 2019?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Which photon energy for intensity-modulated radiotherapy and volumetric-modulated arctherapy in 2019?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Salvage prostate brachytherapy: A solution for local failures after a primary radiation therapy?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Repair and time-dose factor: The example of spinal cord irradiation.
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Hypofractionated irradiation of prostate cancer: What is the radiobiological understanding in 2017?
Follow a manual added link
Pr. Jean-Marc Cosset
Charlebourg-La Défense
Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor location.
Dr. Christine Haie-Meder
La Dr. Christine Haie-Meder possède une grande expérience et une reconnaissance Internationale dans le traitement des cancers gynécologiques et dans tous les domaines de la curiethérapie.
Elle a rejoint Amethyst en mars 2018. Elle était auparavant chef de l’unité de curiethérapie au centre de Lutte contre le Cancer Gustave Roussy.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Place of radiotherapy and surgery in the treatment of cervical cancer patients.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Multimodal imaging guided brachytherapy: the example of cervical cancer.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Brachytherapy: An overview for clinicians
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
Follow a manual added link
Dr. Christine Haie-Meder
Charlebourg-La Défense
Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
Dr. Guillaume Dupic
Oncologue – Radiothérapeute au sein du groupe Amethyst Radiothérapie France, ancien praticien spécialiste et chef de clinique – assistant des hôpitaux au Centre Jean Perrin à Clermont-Ferrand, le Dr. Guillaume Dupic a une orientation préférentielle pour la radiothérapie en onco-neurologie (membre de l’ANOCEF), la radiothérapie stéréotaxique intra et extra crânienne et la radiothérapie prostatique.
Il poursuit une formation médicale continue avec l’inscription cette année au DU de radiochirurgie et radiothérapie en conditions stéréotaxiques intra et extra crânienne.
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Quantification de l’écart de dose entre les algorithmes Monte Carlo et Pencil Beam pour la radiothérapie stéréotaxique pulmonaire
Follow a manual added link
Dr. Guillaume Dupic
Charlebourg-La Défense
Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT)
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Radiochirurgie fonctionnelle : indications et perspectives
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Long-Term Outcomes After Linac Radiosurgery for Benign Meningiomas
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Radiothérapie stéréotaxique des oligométastases surrénaliennes évolutives : efficace et retarde la modification du traitement systémique.
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Radiochirurgie stéréotaxique des schwannomes vestibulaires : 11 Gy en dose d’enveloppe permet de réduire la toxicité.
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Multiple sclerosis as differential diagnosis of radionecrosis for post-irradiation brain lesions: A case report.
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Patterns of Failure After Linear Accelerator Radiosurgery for Cerebral Arteriovenous Malformations.
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Radiothérapie stéréotaxique hypofractionnée des métastases cérébrales de plus de 25 mm sur Novalis® : arcthérapie dynamique conformationnelle ou arcthérapie avec modulation d’intensité?
Follow a manual added link
Dr. Guillaume Dupic
Compiègne
Radionécrose après radiothérapie stéréotaxique d’une métastase cérébrale de 3 cm : la technique peut-elle améliorer les résultats dosimétriques?
Dr. Andres Huertas
Lors de sa formation en radiothérapie à Nancy, le Dr Huertas se spécialise dans la médecine de haute technicité grâce à un plateau technique moderne (VMAT, radiothérapie en conditions stéréotaxiques, curiethérapie guidée par l’image). Il s’intéresse particulièrement à la radiothérapie en conditions stéréotaxiques, sur laquelle il écrit un mémoire et sa thèse d’exercice publiée en 2015 dans le journal Radiotherapy and Oncology. Il a participé à la rédaction de l’article sur la radiothérapie des tumeurs hépatiques dans l’ouvrage de référence français RECORAD.
Il est le lauréat du Prix Lucien Mallet pour l’année 2015.
Follow a manual added link
Dr. Andres Huertas
Creil
Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localised prostate cancers.
Follow a manual added link
Dr. Andres Huertas
Creil
Stereotactic body radiotherapy: Prospective study to evaluate asthenia and quality of life.
Follow a manual added link
Dr. Andres Huertas
Creil
Chemoradiation for oesophageal cancer: A critical review of the literature.
Follow a manual added link
Dr. Andres Huertas
Creil
Management of patients with pacemakers or implantable cardioverter defibrillator undergoing radiotherapy.
Follow a manual added link
Dr. Andres Huertas
Creil
Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.
Follow a manual added link
Dr. Andres Huertas
Creil
Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience.
Follow a manual added link
Dr. Andres Huertas
Creil
Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Follow a manual added link
Dr. Andres Huertas
Creil
Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
Follow a manual added link
Dr. Andres Huertas
Creil
Pelvic radiotherapy in the setting of rheumatoid arthritis: Refining the paradigm.
Follow a manual added link
Dr. Andres Huertas
Creil
RFIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Dr. Anne de la Rochefordière
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Chemotherapy in the treatment of anal canal carcinoma.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
Follow a manual added link
Dr. Anne de la Rochefordière
Charlebourg-La Défense
Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.
Dr. Brigitte Pellae-Cosset
Follow a manual added link
Dr. Brigitte Pellae-Cosset
Compiègne
Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer.
Follow a manual added link
Dr. Brigitte Pellae-Cosset
Compiègne
A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Follow a manual added link
Dr. Brigitte Pellae-Cosset
Compiègne
Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma.
Follow a manual added link
Dr. Brigitte Pellae-Cosset
Compiègne
Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy.
Dr. Elena Roberti
Après une formation à l’UCSC de Rome avec spécialisation en Oncologie Radiothérapie le Dr. Elena Roberti a rejoint en 2002 l’équipe du Pr. Jean Bourhis au sein du Département de Radiothérapie de Gustave Roussy où elle s’est principalement investie dans la prise en charge des cancers digestifs, des sarcomes et des tumeurs mammaires.
Radiothérapeute libérale depuis près de 10 ans elle a décidé de rejoindre le groupe Amethyst Radiothérapie au sein du centre Charlebourg à la Garennes-Colombes.
Follow a manual added link
Dr. Elena Roberti
Charlebourg-La Défense
Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study.
Follow a manual added link
Dr. Elena Roberti
Charlebourg-La Défense
IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?
Follow a manual added link
Dr. Elena Roberti
Charlebourg-La Défense
Place and technical aspects of external beam radiation therapy in the treatment of adult soft tissue sarcomas.
Dr. Laurent Gilbeau
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Harmonization of practices between radiotherapy centres in the Nord and Pas-de-Calais regions (France): A three-year evaluation.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma.
Follow a manual added link
Dr. Laurent Gilbeau
Maubeuge
Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors.
Dr. Louis Bazire
Interne d’oncologie option radiothérapie à Paris, le Dr Bazire s’est formé à la radiothérapie externe de haute technicité et à la curiethérapie. Particulièrement intéressé dès l’externat par les perspectives offertes par l’imagerie moderne, son master 1 traite des techniques d’imagerie médicale.
Il a participé à l’élaboration des recommandations en onco-gériatrie (FROG) et intervient comme orateur au DU d’onco-gériatrie pour les tumeurs gynécologiques.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Radiation therapy after sentinel lymph node biopsy for early stage breast cancer using a magnetic tracer: Results of a single institutional prospective study of tolerance.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Technical aspects and indications of extracranial stereotactic radiotherapy.
Follow a manual added link
Dr. Louis Bazire
Compiègne
The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy-a single center experience.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Doses to organs at risk in conformational radiotherapy and stereotaxic irradiation: The heart.
Follow a manual added link
Dr. Louis Bazire
Compiègne
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Follow a manual added link
Dr. Louis Bazire
Compiègne
Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience.
Dr. Pierre Maroun
Follow a manual added link
Dr. Pierre Maroun
Creil
Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial.
Follow a manual added link
Dr. Pierre Maroun
Creil
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic.
Follow a manual added link
Dr. Pierre Maroun
Creil
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.
Follow a manual added link
Dr. Pierre Maroun
Creil
Why is brachytherapy still essential in 2017?
Follow a manual added link
Dr. Pierre Maroun
Creil
Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
Follow a manual added link
Dr. Pierre Maroun
Creil
Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience.
Follow a manual added link
Dr. Pierre Maroun
Creil
Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae.
Follow a manual added link
Dr. Pierre Maroun
Creil
Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma.
Follow a manual added link
Dr. Pierre Maroun
Creil
Clinical trials and perspectives of radiotherapy for uterine endometrial cancers.
Follow a manual added link
Dr. Pierre Maroun
Creil
Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.
Dr. Thierry Challand
Interne d’oncologie option radiothérapie à Rouen, le Dr Challand s’est formé à la médecine de haute technicité, notamment la Radiothérapie Conformationnelle avec Modulation d’Intensité (RCMI).
Sa formation lui permet une pratique généraliste de sa spécialité, adaptée à la prise en charge de tous types de cancers.
Outre son activité au sein de la clinique AMETHYST de Compiègne, le Dr. Challand est toujours Praticien Attaché (PA) des Hôpitaux de Paris, lui permettant ainsi de mettre régulièrement à jour ses connaissances et compétences sur les dernières innovations médicales et technologiques.
Follow a manual added link
Dr. Thierry Challand
Compiègne
Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
Follow a manual added link
Dr. Thierry Challand
Compiègne
Radiotherapy of a glioma in a pregnant woman: evaluation of the foetal dose in conformational 3D or intensity-modulated.
Follow a manual added link
Dr. Thierry Challand
Compiègne
First measurement of the helicity asymmetry for γp → pπ0 in the resonance region.
Follow a manual added link
Dr. Thierry Challand
Compiègne
Delegation of medical tasks in French radiation oncology departments: current situation and impact on residents’ training.
